NAXYN 250 MG
Country: Israel
Language: English
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
NAPROXEN 250 MG
Available from:
TEVA PHARMACEUTICAL INDUST.LTD
ATC code:
M01AE02
Pharmaceutical form:
TABLETS
Administration route:
PER OS
Manufactured by:
TEVA PHARMACEUTICAL INDUSTRIES LTD
Therapeutic group:
NAPROXEN
Therapeutic indications:
- Relief of the signs and symptoms of rheumatic diseases including osteoarthritis, ankylosing spondylitis of rheumatoid arthritis, both in the treatment of acute flares and in the long-term management of the disease. - Juvenile Rheumatoid Arthritis. - Periarticular and Musculoskeletal Disorders.- Relief of pain in bursitis, tendinitis, synovitis, tenosynovitis and lumbago. - Relief of pain, swelling, tenderness and fever in acute gouty arthritis. - Relief of symptoms of primary dysmenorrhea.
Authorization date:
2009-05-01
